Literature DB >> 26663992

The Ideal Stimulation Protocol: Is There One?

Gautam N Allahbadia1.   

Abstract

Year:  2015        PMID： 26663992      PMCID： PMC4666208          DOI： 10.1007/s13224-015-0723-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  33 in total

Review 1.  Improving the luteal phase after ovarian stimulation: reviewing new options.

Authors:  C Yding Andersen; K Vilbour Andersen
Journal:  Reprod Biomed Online       Date:  2014-02-05       Impact factor: 3.828

2.  Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Federica Esposito; Marco Noventa; Stefania Di Gangi; Stefano Angioni; Pietro Litta; Michele Gangemi; Giovanni Battista Nardelli
Journal:  Gynecol Endocrinol       Date:  2014-09-30       Impact factor: 2.260

3.  Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.

Authors:  M I Cedars; E Surey; F Hamilton; P Lapolt; D R Meldrum
Journal:  Fertil Steril       Date:  1990-04       Impact factor: 7.329

4.  A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.

Authors:  Hakan Cakmak; Nam D Tran; A Musa Zamah; Marcelle I Cedars; Mitchell P Rosen
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

5.  Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation.

Authors:  Luciano G Nardo; Richard Fleming; Colin M Howles; Ernesto Bosch; Samir Hamamah; Filippo M Ubaldi; Jean-Noel Hugues; Adam H Balen; Scott M Nelson
Journal:  Reprod Biomed Online       Date:  2011-05-19       Impact factor: 3.828

6.  Modified natural cycle in vitro fertilization an alternative in vitro fertilization treatment with lower costs per achieved pregnancy but longer treatment time.

Authors:  Michael von Wolff; Susanne Rohner; Alessandro Santi; Petra Stute; Roxana Popovici; Benedicte Weiss
Journal:  J Reprod Med       Date:  2014 Nov-Dec       Impact factor: 0.142

7.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

8.  Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone.

Authors:  R Fleming; F Lloyd; M Herbert; J Fenwick; T Griffiths; A Murdoch
Journal:  Hum Reprod       Date:  1998-07       Impact factor: 6.918

9.  Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.

Authors:  S Jacob; L Drudy; R Conroy; R F Harrison
Journal:  Hum Reprod       Date:  1998-07       Impact factor: 6.918

Review 10.  GnRH antagonists in assisted reproductive techniques: a review on the Italian experience.

Authors:  R Marci; A Graziano; G Lo Monte; I Piva; I Soave; E Marra; F Lisi; M Moscarini; D Caserta
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-04       Impact factor: 3.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.